NURI J JACOBY

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NEW YORK, NY NPI 1275769747

General Payments — all program years on this page

$13,747.55

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,607.66 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $5,894.632
Food and Beverage $597.2615
Travel and Lodging $115.771

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $6,338.896
SK Life Science, Inc. $80.113
Acerta Pharma LLC $64.804
EISAI INC. $30.641
Marinus Pharmaceuticals, Inc. $25.431
ARGENX US, INC. $25.011
Neurelis, Inc. $22.891
UCB, Inc. $19.891

By program year

Program yearAmountRecords
2018 $669.8233
2019 $371.6620
2020 $2,249.217
2021 $233.124
2022 $1,560.893
2023 $2,055.197
2024 $6,607.6618

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104382209 AstraZeneca Pharmaceuticals LP $14.81 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104785630 AstraZeneca Pharmaceuticals LP $19.37 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105218320 AstraZeneca Pharmaceuticals LP $17.30 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105403725 AstraZeneca Pharmaceuticals LP $13.32 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110770813 Eisai Inc. $30.64 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115757347 Amgen Inc. $4,125.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115757358 Amgen Inc. $1,769.63 10/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115757366 Amgen Inc. $28.50 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115757376 Amgen Inc. $115.77 11/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1115757384 Amgen Inc. $150.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115757391 Amgen Inc. $149.99 10/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141323822 Marinus Pharmaceuticals, Inc. $25.43 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142109437 ARGENX US, INC. $25.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143385768 UCB, Inc. $19.89 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145644068 Neurelis, Inc. $22.89 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154130297 SK Life Science, Inc. $26.39 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154130303 SK Life Science, Inc. $23.85 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154130369 SK Life Science, Inc. $29.87 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.